2.27
Finanzdaten der Sana Biotechnology Inc-Aktie (SANA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
34.57%
65.42
|
48.61 | 61.20 | 43.52 | 94.97 |
| Operating Income/Loss |
34.57%
-65.42
|
-48.61 | -61.20 | -43.52 | -94.97 |
| Net Income/Loss |
34.79%
-63.63
|
-47.21 | -58.83 | -42.15 | -93.80 |
| Basic Average Shares |
6.79%
295.67
|
276.86 | 7.654 | 260.49 | 238.41 |
| Diluted Average Shares |
6.79%
295.67
|
276.86 | 7.654 | 260.49 | 238.41 |
| Basic Earnings Per Share |
29.41%
-0.22
|
-0.17 | -0.21 | -0.16 | -0.39 |
| Diluted Earnings Per Share |
29.41%
-0.22
|
-0.17 | -0.21 | -0.16 | -0.39 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):